Monday January 21, 2019

New Drug to Give Hopes to Bone Marrow Cancer Patients

It reduced the risk of progression or death by more than 50 per cent in both groups

0
//
Cancer
Cancer Ribbon. Pixabay

A therapeutic drug has been found to improve outcomes and survival rates for patients with a serious type of bone marrow cancer.

In a clinical trial by researchers at Newcastle University in Britain, patients with newly diagnosed myeloma were treated with a drug called lenalidomide.

The results, published in the journal The Lancet Oncology, showed an improvement for those who received lenalidomide drug, compared to those not receiving it.

“This is a major breakthrough as it shows that the long-term use of lenalidomide significantly improves the time myeloma patients stay in remission after initial therapy,” said Professor Graham Jackson from the Northern Institute for Cancer Research at Newcastle.

Myeloma is a cancer of the plasma cells and it can affect several areas of the body, such as the spine, skull, pelvis and ribs. Current treatment usually involves chemotherapy and a stem-cell transplant.

cancer
New drug offers hope for bone marrow cancer patients. Pixabay

“It is a huge step and, importantly, identifies that for younger patients lenalidomide improves their overall survival for this difficult-to-treat bone marrow cancer,” Jackson said.

“Our research highlights that lenalidomide should be considered for newly diagnosed patients following stem-cell transplantation,” he added.

As part of the study, a total of 1,137 newly diagnosed patients were randomly assigned to lenalidomide maintenance therapy and 834 patients to observation – this was after they completed their initial treatment.

Also Read- Narendra Modi Accuses Congress of Aiding Those Who Want to Weaken Army

The results show that lenalidomide can prolong the average remission time by more than two years in younger patients and by well over a year in older, less fit patients.

It reduced the risk of progression or death by more than 50 per cent in both groups. (IANS)

Next Story

Risk Of Suicide Quadruples With Cancer: Study

The results could be used to help identify patients who may be at a higher risk for suicide and help health care providers tailor their treatments accordingly.

0
A Family In Delhi Commits Suicide To Thank God: Police Reports
While the risk of suicide decreases five years after a diagnosis, the risk remains high for patients with Hodgkin lymphoma and testicular cancer.

People with cancer are over four times more likely to commit suicide than people without the deadly disease, finds a study.

According to researchers from the Penn State Cancer Institute in Pennsylvania, while a lot of progress has been made in treating cancer, not as much research has been put into how cancer affects patients mentally and emotionally.

“Even though cancer is one of the leading causes of death, most cancer patients do not die from cancer, the patients usually die of another cause,” said Nicholas Zaorsky, radiation oncologist at the Penn State Cancer Institute.

“There are multiple competing risks for death, and one of them is suicide. Distress and depression can arise from cancer diagnosis, treatment, financial stress, and other causes. Ultimately, distress and depression may lead to suicide. Our goal was to quantify the risk of suicide among cancer patients,” he added.

Breast Cancer
Chemists develop unique disease-fighting ‘nano-grenades’. VOA

The study, published in the Nature Communications journal, the team compared the risk of suicide in eight million patients who had been diagnosed with cancer and those without.

They found that among people with cancer, males, patients who were diagnosed at a younger age, patients with lung, head, neck and testicular cancer, and lymphomas were more likely to commit suicide.

While the risk of suicide decreases five years after a diagnosis, the risk remains high for patients with Hodgkin lymphoma and testicular cancer.

“Treatments for some cancers — like leukemia and testicular cancer among adolescents and young adults, for example — can decrease a patient’s fertility, and that seems to be one of the risks for suicide in the long term,” Zaorsky said.

Also Read: Here’s What Causes Cancer in Children

“In contrast, elderly patients who are diagnosed with lung, prostate and head and neck cancers, are at an increased risk of suicide for the remainder of their life.”

The results could be used to help identify patients who may be at a higher risk for suicide and help health care providers tailor their treatments accordingly. (IANS)